Title : In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.

Pub. Date : 2016 Jul

PMID : 26990650






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The cause of this disease is the expansion of a CAG repeat in the so-called ATXN3 gene leading to an expanded polyglutamine stretch in the ataxin-3 protein. polyglutamine ataxin 3 Mus musculus
2 The cause of this disease is the expansion of a CAG repeat in the so-called ATXN3 gene leading to an expanded polyglutamine stretch in the ataxin-3 protein. polyglutamine ataxin 3 Mus musculus